Product Description
Ki-67 may be considered as a valuable biomarker in breast cancer patients.
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Large Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: AstraZeneca
Company Location: CAMBRIDGE X0 CB2 0AA
Company CEO: Pascal Soriot
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Non-Small-Cell Lung Cancer
Phase 2: Breast Cancer
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| Compass | N/A |
Completed |
Cervical Cancer|Papilloma |
2014-12-01 |
|
| PROSPER 1 | N/A |
Recruiting |
Breast Cancer |
None |
|
| ChiCTR1900022725 | N/A |
Completed |
Oncology Unspecified |
2019-08-31 |
|
| ChiCTR2000029231 | N/A |
Not yet recruiting |
Cervical Cancer |
2022-05-01 |
|
| ChiCTR2000038578 | N/A |
Not yet recruiting |
Breast Cancer |
2022-12-31 |
|
| ChiCTR2100048119 | N/A |
Completed |
Glioma |
2020-12-01 |
|
| ChiCTR2100054094 | N/A |
Recruiting |
Liver Cancer |
2023-12-01 |
|
| ChiCTR2100054369 | N/A |
Recruiting |
Adenocarcinoma |
2023-12-31 |
|
| ChiCTR2200055502 | N/A |
Recruiting |
Breast Cancer |
2022-12-31 |
|
| ChiCTR2400079698 | N/A |
Not yet recruiting |
Breast Cancer |
2026-12-31 |
|
| ChiCTR2500095524 | N/A |
Not yet recruiting |
Cervical Cancer |
2028-12-31 |
|
| ChiCTR-OOC-15006925 | N/A |
Recruiting |
Ovarian Cancer |
2017-09-01 |
|
| 1839IL/0052 SubStudy | P4 |
Completed |
Non-Small-Cell Lung Cancer |
2010-04-01 |
|
| 2019-09-05-001-R1 | N/A |
Completed |
Vaginal Cancer|Dysgerminoma|Cell Transformation, Neoplastic|Teratoma|Lymphoma|Colorectal Cancer|Ovarian Cancer|Cervical Cancer|Papilloma|Squamous Cell Carcinoma|Lung Cancer|Adenomyosis|NUT Carcinoma |
2021-04-01 |
|
| IHS for Wilms tumour relapse | N/A |
Unknown status |
Wilms Tumor |
2021-03-01 |
|
| MORE-T | P2 |
Active, not recruiting |
Breast Cancer |
2024-12-31 |
|
| I-share | N/A |
Recruiting |
Cervical Cancer|Uterine Cancer |
2027-02-01 |
|
| NeoTAILOR | P2 |
Recruiting |
Breast Cancer |
2027-11-30 |
|
| STUDY00006091 | N/A |
Recruiting |
Squamous Cell Carcinoma|Anal Cancer |
2027-10-01 |